# ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
> **ANDA090309** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMA · Approved 2009-07-15
## Drug
- **FDA Application Number:** ANDA090309
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
- **Generic name:** Abacavir Sulfate
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMA
- **First approval:** 2009-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090309)
---
*AI Analytics · CC0 1.0*